The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia.

Read research from the February 2023 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapy drugs for treating people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

A study from China published in the Journal of Clinical Oncology has shown that CAR T-cell therapy that targets CD19 and CD22 is effective at treating recurrent or refractory acute lymphoblastic leukemia in children.

Dr. Craig A. Portell discusses what CAR T-cell therapy is, how it works, what its common side effects are, and how it’s changing the landscape of how some types of cancers are treated.

Be The Match, the national bone marrow transplant registry, needs people of different racial and ethnic backgrounds to volunteer as donors. Learn why having diversity in the registry is important, what disparities exist, and how to sign up.

In this post, Rachel Engstrom describes how she learned to cope during her husband’s cancer diagnosis and after his death, including how she found support throughout the experience.

In this podcast, Dr. Michael Williams discusses studies and a report on the treatment of leukemia and lymphoma presented at last month’s ASH Annual Meeting.

In this podcast, Cancer.Net Associate Editors share exciting research from the ASCO20 Virtual Scientific Program.

After being diagnosed with acute myeloid leukemia (AML) at age 15, Hernan Barangan felt isolated and scared. Later, it led him to a new career path in filmmaking where he’s helping other young adults with cancer.

Journalist Loriana Hernandez-Aldama wasn’t expecting to hear she had cancer again -- and it was a different type than her first diagnosis. Here’s how she learned to cope with her secondary cancer diagnosis and prepare for treatment.